Search Press releases Keywords From To 8 Jan 2019 EVENITY® (romosozumab) Receives Approval In Japan for the Treatment of Osteoporosis In Patients at High Risk of Fracture Read More 8 Jan 2019 Transparency notification UCB SA/NV Read More 30 Dec 2018 Transparency notifications BlackRock, Inc. Read More 12 Dec 2018 Transparency notifications BlackRock, Inc. Read More 2 Dec 2018 UCB announces approval of VIMPAT® in China Read More 30 Nov 2018 UCB and Amgen Announce FDA Advisory Committee Meeting to review EVENITY™ (Romosozumab) for the Treatment of Osteoporosis in Postmenopausal Women at High Risk for Fracture Read More Pagination First page Previous page Previous … Page 63 Page 64 Page 65 Page 66 Current page 67 Page 68 Page 69 Page 70 Page 71 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
